KSP Inc.

KSP Inc. operates the Kanagawa Science Park (KSP), Japan's first urban science park, providing a comprehensive suite of services to foster innovation and business development. These services include office and laboratory leasing, venture investment funds, business matching, a business school, an acceleration program, and biotech support. By offering these resources, KSP Inc. aims to create new industries and support the growth of early and middle-stage companies.

The company's investment focus spans various sectors, including health tech, biotechnology, artificial intelligence, and robotics. KSP Inc. has managed multiple investment funds since 1997, investing in approximately 100 high-tech venture companies. Notable exits include Megakaryon, Kringle Pharma, and Rena Therapeutics. The firm is committed to supporting startups and innovators in Japan, providing both financial and strategic assistance to help them succeed in the competitive market.

KSP Inc. also emphasizes collaboration with domestic and international incubators and science parks, contributing to regional and international communities through the creation of new businesses. By strengthening support for Japanese startups entering overseas markets and promoting exchanges between overseas venture companies and Japanese companies, KSP Inc. aims to become a global platform for R&D companies in Asia. This network approach enhances the growth and scalability of its portfolio companies, fostering a dynamic entrepreneurial ecosystem.